More on AMGN
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $379.78 |
|
|||
| Open | $378.51 | ||||
| 52 Wk High | $176.85 | ||||
| 52 Wk Low | $133.64 | ||||
| Day High | $386.50 | ||||
| Day Low | $378.51 | ||||
| P/E | 58.08 | ||||
| EPS | $6.64 | ||||
| Volume | 8,467,045 | ||||
- Amgen (AMGN) PT Lowered to $430 at UBS
- FDA cuts monitoring time for Amgen's Imdelltra initial doses
- FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA®
- HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review
- HSBC Downgrades Amgen (AMGN) to Hold
- AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
- BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts
- Amgen (AMGN) call put ratio 1 call 1 put
- BMO Capital Downgrades Amgen (AMGN) to Market Perform
- Amgen (AMGN) PT Raised to $435 at Wells Fargo
Entities mentioned with amgn
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- Dividend | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
